Antitumor activity against human KARPAS422 cells xenografted in SCID mouse assessed as reduction in tumor re-growth at 50 to 100 mg/kg, po dosed daily...

Basic Information

ID: ALA4613070

Type: Functional

Description: Antitumor activity against human KARPAS422 cells xenografted in SCID mouse assessed as reduction in tumor re-growth at 50 to 100 mg/kg, po dosed daily for 28 days followed by treatment cessation for 72 days relative to control

Format: BAO_0000218

Organism: Homo sapiens

Cell type: KARPAS-422

Target:  KARPAS-422(ALA2366368)

Document:  ALA4610126

Antitumor activity against human KARPAS422 cells xenografted in SCID mouse assessed as reduction in tumor re-growth at 50 to 100 mg/kg, po dosed daily for 28 days followed by treatment cessation for 72 days relative to control: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
467.533.503.50
479.543.763.76